Skip to main content
logo
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.1650
+0.0050 (3.13%)
Jul 31, 2026, 4:10 PM AEST

ASX:PAR Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
0.01---0.080.02
Revenue Growth
----285.52%-
Gross Profit
0-0.02-0.01-0.02-0.06-0.08
Operating Income
-38.82-23.34-65.11-60.09-47.93-43.18
Net Income
-36.09-18.77-58.73-51.91-39.25-34.3
Earnings Per Share
-0.10-0.06-0.20-0.21-0.17-0.15
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
14.7416.8217.8756.3839.7271.08
Total Debt
9.380.010.240.340.620.75
Net Cash (Debt)
5.3616.8117.6356.0439.170.33
Net Cash Growth
-68.14%-4.62%-68.54%43.30%-44.40%-32.22%
Net Cash Per Share
0.020.050.060.220.170.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-27.42-15.99-65.94-45.19-32.21-34.93
Capital Expenditures
------0.03
Free Cash Flow
-27.42-15.99-65.94-45.19-32.21-34.96
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
24.53%----81.45%-
Operating Margin
-459439.36%----60498.78%-210124.38%
Pretax Margin
-427113.40%----49542.54%-166896.27%
Profit Margin
-427113.40%----49542.54%-166896.27%
FCF Margin
-324524.20%----40650.90%-170122.95%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-14.0514.05---
PS Ratio
11598.44---2829.6423494.01